Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Walter Crook

Psychiatry Willmar, MN Medical Doctor

NPI 1437372729 CMS profile 1201175

1701 Technology Dr Ne, Willmar, MN 56201

Open in the dashboard

General payments

$896

53 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Walter Crook of Willmar, MN is reported in the CMS Open Payments database as having received $896 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $115 6
2024 General $19 1
2023 General $142 9
2022 General $93 5
2021 General $221 13
2020 General $307 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Walter Crook
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Walter Crook were reported at $115. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Walter Crook Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $307 $119 $36–$372 $114
2021 $221 $143 $43–$576 $132
2022 $93 $153 $50–$590 $149
2023 $142 $170 $56–$651 $160
2024 $19 $179 $57–$673 $164
2025 $115 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Janssen Pharmaceuticals, Inc $277 17 payments
  2. Alkermes, Inc. $254 15 payments
  3. Otsuka America Pharmaceutical, Inc. $179 10 payments
  4. ITI, Inc. $52 3 payments
  5. Lundbeck LLC $50 3 payments
  6. Teva Pharmaceuticals USA, Inc. $37 2 payments
  7. BioXcel Therapeutics, Inc. $33 2 payments
  8. Arbor Pharmaceuticals, Inc. $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $896 53 payments
Products named General payments · program years 2020–2025
  1. INVEGA SUSTENNA $277 17 payments
  2. ARISTADA Cns $254 15 payments
  3. ARISTADA Cns $254 15 payments
  4. ARISTADA Cns $207 12 payments
  5. ARISTADA Cns $207 12 payments
  6. ARISTADA INITIO $180 10 payments
  7. ABILIFY MAINTENA $177 10 payments
  8. INVEGA TRINZA $150 9 payments
  9. LYBALVI $120 8 payments
  10. CAPLYTA $52 3 payments
  11. Other $234 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record